Allergy Shots Process: Your Multi-Year Patient Journey Explained
The allergy shots process is a three-phase multi-year journey: build-up (monthly weekly visits), early maintenance (every 2 weeks), and full maintenance (every 2–4 weeks for 3–5 years). Total: roughly 95 visits, 35–45 minutes each. Only 43.9% of patients reach maintenance in real-world data (Tkacz 2021, n=103,207). Improvement begins around 6–12 months; full benefit by Year 2–3; durable remission per Durham 1999 NEJM.
6 peer-reviewed sources
The allergy shots process spans three phases over 3–5 years: weekly build-up for 6 months, every-2-week early maintenance for 6 months, then every-2-to-4-week full maintenance for 3–5 years — approximately 95 total visits at 35–45 minutes each.
The essentials
The allergy shots process, from the patient's perspective, is a three-phase calendar commitment spanning 3–5 years and approximately 95 separate injection visits, each lasting 35–45 minutes.
Curex pairs at-home IgE testing with allergist review to identify the allergens that would justify a 3-to-5-year commitment — the diagnostic step that determines whether the ~95-visit journey is even clinically warranted.
Phase 1 — Build-up (Months 0–6, approximately 24–28 weekly visits per Cox 2011 PP3): this is the highest-frequency phase. Weekly visits, each 35–45 minutes including the mandatory 30-minute observation. Doses escalate from 0.05 mL of the most dilute vial to 0.5 mL of the maintenance concentrate. Most local reactions occur here. Most dropout occurs here: per Tkacz et al. (Curr Med Res Opin 2021;37[6]:957–965, IBM MarketScan 2014–2017, n=103,207 AIT patients), 23.9% of patients never returned after the first injection. The visit frequency is the barrier — not the needle itself.
Phase 2 — Early maintenance (Months 6–12, approximately 13 visits at every 2 weeks): the dose is now stable at the maintenance concentrate. Visit frequency drops to every 2 weeks. Subjective symptom improvement typically begins here — many patients first notice they are sneezing less or using less antihistamine during this phase.
Phase 3 — Full maintenance (Years 2–5, approximately 14–18 visits per year at every 2–4 weeks): the disease-modifying phase. Most US clinics settle into a monthly cadence. Symptom improvement deepens. The durable tolerance that Durham et al. (NEJM 1999) documented as persisting for years after stopping builds during this phase. The Jacobsen et al. (Allergy 2007) PAT study showed that 3 years of SCIT in allergic children reduced new asthma onset for up to 7 years after treatment ended — this protective effect accumulates during maintenance.
Per the Tkacz 2021 data, only 43.9% of AIT patients reached the maintenance phase. Patients who begin SCIT should understand upfront that the process selects against those who cannot maintain the visit cadence — particularly the weekly Year 1 schedule.
For patients who want the same three-phase disease-modifying outcome without the clinic visit burden, Curex's At-Home Allergy Shot Kit (scit-v1) at $129/month delivers the full conventional escalation protocol — same mechanism, same 3-to-5-year course, one weekly at-home injection — with the first dose and every dose change supervised live over Zoom by the prescribing allergist and a prescribed epinephrine auto-injector confirmed on hand before the first injection.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The three phases of the allergy shots process differ in visit frequency, clinical focus, and patient experience. Understanding the phase structure helps patients plan and persist through the year-one build-up when dropout risk is highest.
Escalating doses weekly from 0.05 mL of most dilute vial to 0.5 mL of maintenance concentrate. 35–45 min per visit. Highest local-reaction frequency (~78% of patients, Calabria LOCAL). Highest dropout risk — 23.9% of patients do not return after first injection (Tkacz 2021).
Stable maintenance concentrate dose. Every-2-week cadence. Subjective symptom improvement typically begins here. Transition from build-up frequency marks a quality-of-life improvement in visit burden.
Monthly or near-monthly injections. Disease-modifying tolerance accumulates per Durham 1999 NEJM and Jacobsen 2007 PAT. 30-minute observation at every visit. Discontinuation decision at Year 5 based on clinical response.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
What is the allergy shots process from start to finish?
The allergy shots process runs from initial IgE testing through a 3-to-5-year treatment course. First, a board-certified allergist confirms IgE sensitization via skin or blood testing and identifies which allergens are clinically relevant. Second, a patient-specific allergen extract vial set is prepared from FDA-licensed source materials. Third, the build-up phase begins: weekly clinic visits for approximately 6 months, each 35–45 minutes including mandatory 30-minute observation per Cox 2011 PP3. Fourth, early maintenance: every-2-week visits for 6 more months. Fifth, full maintenance: every 2–4 weeks for 3–5 years, where the disease-modifying tolerance documented by Durham 1999 accumulates. Sixth, discontinuation: a clinical decision at approximately Year 5 based on symptom response.
When do allergy shots start working?
Subjective symptom improvement typically begins 6–12 months into the allergy shot process, during early maintenance, when the patient has been at the full maintenance dose for several months. Full benefit usually becomes apparent by Year 2–3. The immunological changes begin earlier — IgG4 blocking antibodies start rising within 1–3 months of build-up — but the clinical threshold where most patients notice meaningful symptom reduction is early maintenance. Per the Calderon 2007 Cochrane review (51 RCTs, 2,871 patients), the pooled symptom SMD is −0.73, corresponding to roughly a one-third reduction in nasal symptom severity. Most patients notice the difference most clearly during their previously worst allergy seasons in Years 2–3.
Why is Year 1 of allergy shots so hard to stick with?
Year 1 requires weekly clinic visits, each approximately 35–45 minutes including mandatory observation. For a working adult, 26 separate weekly half-hour clinic visits represent approximately 15–20 hours of total clinic time plus travel — a substantial commitment. Per Tkacz et al. (Curr Med Res Opin 2021, n=103,207 AIT patients), 23.9% of patients never returned for a second injection, and only 43.9% ever reached maintenance. The barrier is not pain from the needle; most patients describe the needle as brief and mild. The barrier is logistics — scheduling weekly visits around work, school, and family, and the mandatory observation period that prevents in-and-out visits.
What happens if I stop allergy shots early?
Stopping allergy shots before completing 3 years of maintenance substantially reduces the likelihood of achieving durable long-term tolerance. The Durham 1999 NEJM study showed that 3–4 years of grass-pollen SCIT at the maintenance dose produced remission persisting for years after stopping — but this benefit requires reaching and sustaining the maintenance dose for that duration. Stopping in the build-up phase means the tolerance process was never completed. Stopping after Year 1 of maintenance may provide partial benefit but less than the disease-modifying durability documented after 3+ years. The allergist and patient should discuss the risk-benefit calculus before stopping early; for some patients, partial benefit may still be meaningful.
How does the process differ for cluster vs conventional allergy shots?
The process structure is identical across conventional, cluster, and rush schedules — six visit steps per Cox 2011 — but the build-up phase duration and per-visit injection count differ. Conventional schedule: one injection per visit, weekly, ~24–28 visits over 6 months. Cluster schedule (Tabar 2005): 2–4 injections per visit at ≥30-minute intervals; maintenance in ~4–8 weeks. Rush schedule: multiple injections per day for 1–3 days; maintenance in days. After maintenance is reached, all schedules follow the same every-2-to-4-week maintenance cadence for 3–5 years. Cluster and rush carry approximately 3× and up to 36× higher per-injection systemic-reaction risk respectively, requiring closer monitoring and premedication.
How do I know if the allergy shot process is working for me?
Clinical improvement usually becomes noticeable in early maintenance — approximately 6–12 months into the process. Signs the process is working: reduced nasal symptoms during previously symptomatic seasons, less frequent antihistamine use, smaller local reactions per visit compared to early build-up, and improvement in asthma control in asthmatic patients. Objective markers include decreasing skin test reactivity to confirmed allergens over time (when re-tested) and rising allergen-specific IgG4 levels if measured. Per Cox 2011 PP3, if no clinical improvement is evident after 12 full months at the maintenance dose, the allergist should reassess allergen selection, dosing adequacy, and whether SCIT is the right approach. Subtherapeutic dosing and missed allergens are the most common reasons for non-response.
What pre-visit preparation helps the allergy shots process go smoothly?
Per Cox 2011 PP3, several pre-visit steps reduce reaction risk and support a smooth process. Avoid vigorous exercise for approximately 2 hours before the injection — exercise increases systemic allergen absorption and may increase reaction risk. Avoid hot showers or baths immediately after the injection for the same reason. Inform your clinic of any new medications before your visit, particularly beta-blockers (which can impair epinephrine response in anaphylaxis) and ACE inhibitors. Flag any worsening asthma symptoms, fever, or acute illness before receiving an injection — these can increase reaction risk and may be grounds for postponing that day's shot. Antihistamine premedication is sometimes recommended by the allergist to reduce local reactions; follow your clinic's specific guidance.
Related Articles
Cat Allergy Vaccine Explained | Curex SCIT Guide
Cat allergy vaccine means three different things. SCIT uses FDA-standardized Fel d 1 extract for ~72% symptom relief. No one-shot cure exists.
Read moreAllergy Shot Process: 6-Step Visit Protocol | Curex Guide
Allergy shot process: 6 steps — screen, verify vial, inject, 30-min observe, measure wheal, discharge. 35–45 min per Cox 2011 PP3. At-home SCIT option.
Read moreHow Do Allergy Shots Work? Immune Mechanism | Curex 2025
Allergy shots work through IgG4 blocking antibodies and regulatory T cells. Full science-backed explanation of the molecular cascade behind SCIT.
Read moreRed Vial Allergy Shots: Maintenance Concentrate | Curex
The red vial is the maintenance concentrate in allergy shots — not the starting dilute vial. Learn what reaching it means and why labels beat colors.
Read moreAllergy Shot Ingredients: FDA-Verified Breakdown | Curex
Allergy shots contain allergen extract, diluent (50% glycerin or saline), phenol 0.4% preservative, and buffer salts. FDA CBER-anchored ingredient guide.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots use FDA-standardized Fel d 1 extract for ~72% symptom relief. RCT evidence, schedule, plus at-home SCIT from Curex at $129/mo.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.